» Articles » PMID: 39364622

Characterization and Biological Activity of Selenium Nanoparticles Biosynthesized by Yarrowia Lipolytica

Overview
Date 2024 Oct 4
PMID 39364622
Authors
Affiliations
Soon will be listed here.
Abstract

In this research, biogenic selenium nanoparticles were produced by the fungi Yarrowia lipolytica, and the biological activity of its nanoparticles was studied for the first time. The electron microscopy analyses showed the production of nanoparticles were intracellular and the resulting particles were extracted and characterized by XRD, zeta potential, FESEM, EDX, FTIR spectroscopy and DLS. These analyses showed amorphous spherical nanoparticles with an average size of 110 nm and a Zeta potential of -34.51 ± 2.41 mV. Signatures of lipids and proteins were present in the capping layer of biogenic selenium nanoparticles based on FTIR spectra. The antimicrobial properties of test strains showed that Serratia marcescens, Klebsiella pneumonia, Escherichia coli, Pseudomonas aeruginosa and Bacillus subtilis were inhibited at concentrations between 160 and 640 μg/mL, while the growth of Candida albicans was hindered by 80 μg/mL of biogenic selenium nanoparticles. At concentrations between 0.5 and 1.5 mg/mL of biogenic selenium nanoparticles inhibited up to 50% of biofilm formation of Klebsiella pneumonia, Acinetobacter baumannii, Staphylococcus aureus and Pseudomonas aeruginosa. Additionally, the concentration of 20-640 μg/mL of these bioSeNPs showed antioxidant activity. Evaluating the cytotoxicity of these nanoparticles on the HUVEC and HepG2 cell lines did not show any significant toxicity within MIC concentrations of SeNPs. This defines that Y. lipolytica synthesized SeNPs have strong potential to be exploited as antimicrobial agents against pathogens of WHO concern.

Citing Articles

Microbes Saving Lives and Reducing Suffering.

Timmis K, Karahan Z, Ramos J, Koren O, Perez-Cobas A, Steward K Microb Biotechnol. 2025; 18(1):e70068.

PMID: 39844583 PMC: 11754571. DOI: 10.1111/1751-7915.70068.


Characterization and biological activity of selenium nanoparticles biosynthesized by Yarrowia lipolytica.

Lashani E, Moghimi H, Turner R, Amoozegar M Microb Biotechnol. 2024; 17(10):e70013.

PMID: 39364622 PMC: 11450378. DOI: 10.1111/1751-7915.70013.

References
1.
Fernandez-Llamosas H, Castro L, Blazquez M, Diaz E, Carmona M . Biosynthesis of selenium nanoparticles by Azoarcus sp. CIB. Microb Cell Fact. 2016; 15(1):109. PMC: 4908764. DOI: 10.1186/s12934-016-0510-y. View

2.
Baggio G, Groves R, Chignola R, Piacenza E, Presentato A, Lewis I . Untargeted Metabolomics Investigation on Selenite Reduction to Elemental Selenium by SeITE01. Front Microbiol. 2021; 12:711000. PMC: 8481872. DOI: 10.3389/fmicb.2021.711000. View

3.
Akcay F, Avci A . Effects of process conditions and yeast extract on the synthesis of selenium nanoparticles by a novel indigenous isolate Bacillus sp. EKT1 and characterization of nanoparticles. Arch Microbiol. 2020; 202(8):2233-2243. DOI: 10.1007/s00203-020-01942-8. View

4.
Huang X, Chen X, Chen Q, Yu Q, Sun D, Liu J . Investigation of functional selenium nanoparticles as potent antimicrobial agents against superbugs. Acta Biomater. 2015; 30:397-407. DOI: 10.1016/j.actbio.2015.10.041. View

5.
Zhang H, Li Z, Dai C, Wang P, Fan S, Yu B . Antibacterial properties and mechanism of selenium nanoparticles synthesized by Providencia sp. DCX. Environ Res. 2020; 194:110630. DOI: 10.1016/j.envres.2020.110630. View